What is he best known for?
The fields of study he is best known for:
- Cancer
- Surgery
- Internal medicine
Richard R. Barakat spends much of his time researching Surgery, Gynecology, Endometrial cancer, Ovarian cancer and Carcinoma.
As part of his studies on Surgery, he often connects relevant subjects like Stage IIIC.
His Gynecology study combines topics from a wide range of disciplines, such as Cancer, Internal medicine, Gynecologic oncology, Risk factor and Obstetrics.
His Endometrial cancer research is multidisciplinary, incorporating elements of Sentinel lymph node, Clinical trial, Radiology, Dissection and Sentinel node.
His Ovarian cancer research is multidisciplinary, relying on both Combined Modality Therapy, Multivariate analysis and Oncology.
His studies deal with areas such as BRCA mutation and Incidence as well as Oncology.
His most cited work include:
- Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation. (1060 citations)
- Gemcitabine and Docetaxel in Patients With Unresectable Leiomyosarcoma: Results of a Phase II Trial (541 citations)
- Clinicopathologic Features of BRCA-Linked and Sporadic Ovarian Cancer (479 citations)
What are the main themes of his work throughout his whole career to date?
Richard R. Barakat focuses on Surgery, Internal medicine, Oncology, Endometrial cancer and Ovarian cancer.
His studies examine the connections between Surgery and genetics, as well as such issues in Carcinoma, with regards to Adenocarcinoma.
His Internal medicine research includes themes of Gastroenterology and Gynecology.
The study incorporates disciplines such as Paclitaxel, Incidence, Family history and Epithelial ovarian cancer in addition to Oncology.
His Endometrial cancer research focuses on subjects like Hysterectomy, which are linked to Lymphovascular invasion.
His Ovarian cancer research incorporates elements of Disease and Fallopian tube.
He most often published in these fields:
- Surgery (42.02%)
- Internal medicine (38.45%)
- Oncology (30.46%)
What were the highlights of his more recent work (between 2013-2021)?
- Internal medicine (38.45%)
- Oncology (30.46%)
- Surgery (42.02%)
In recent papers he was focusing on the following fields of study:
Richard R. Barakat mostly deals with Internal medicine, Oncology, Surgery, In patient and Endometrial cancer.
His biological study spans a wide range of topics, including Adjuvant chemotherapy, Breast cancer, Adjuvant therapy and Epithelial ovarian cancer.
The various areas that he examines in his Surgery study include Uterine cancer and General surgery.
Richard R. Barakat has researched Uterine cancer in several fields, including Hysterectomy, Interquartile range and Carcinoma.
His study in Endometrial cancer is interdisciplinary in nature, drawing from both Lymphedema, Lynch syndrome, Cervical cancer, Lymphadenectomy and Vulvar cancer.
His Incidence study combines topics in areas such as Lymph node and Cohort.
Between 2013 and 2021, his most popular works were:
- Uterine Cancer After Risk-Reducing Salpingo-oophorectomy Without Hysterectomy in Women With BRCA Mutations. (114 citations)
- Impact of Obesity on Sentinel Lymph Node Mapping in Patients with Newly Diagnosed Uterine Cancer Undergoing Robotic Surgery (34 citations)
- GOG 244-The lymphedema and gynecologic cancer (LEG) study: Incidence and risk factors in newly diagnosed patients (15 citations)
In his most recent research, the most cited papers focused on:
- Cancer
- Internal medicine
- Surgery
Richard R. Barakat mainly focuses on Endometrial cancer, Internal medicine, Cancer, Lymphadenectomy and Vulvar cancer.
His Internal medicine study frequently draws connections to adjacent fields such as Oncology.
Richard R. Barakat combines subjects such as Endometrial biopsy, Endometrial hyperplasia, Metabolic syndrome, Sentinel node and Cowden syndrome with his study of Oncology.
His Cancer study integrates concerns from other disciplines, such as Psychological intervention, Psychiatry, Reproductive health, Chronic condition and Physical therapy.
His research integrates issues of Incidence, Radical surgery, Gynecologic cancer and Cohort in his study of Lymphadenectomy.
His Vulvar cancer research is multidisciplinary, incorporating perspectives in Lymphedema, Gynecologic oncology, Clinical trial, Cervical cancer and Quality of life.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
